Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025

3-(4-{ [4-(4-{ [3-(3, 3-dimethyl-1-piperidinyl) propyl] oxy} phenyl)-1-piperidinyl] carbonyl}-1-naphthalenyl) propanoic or propenoic acid as H1 and H3 receptor antagonists for the treatment of inflammatory and/or allergic disorders

US Patent 7989629 · Granted Aug 2, 2011

Assignee

Inventors

View full patent text on Google Patents →